Turkey Electrocardiograph (ECG) Market Size
Turkey Electrocardiograph (ECG) Market Analysis
The Turkey Electrocardiograph Market size is estimated at USD 10.83 million in 2025, and is expected to reach USD 14.71 million by 2030, at a CAGR of 6.31% during the forecast period (2025-2030).
The aging population in Turkey is significantly contributing to the expansion of the ECG market, with a notable rise in the demand for ECG equipment. This trend is primarily driven by the growing incidence of heart diseases such as congestive heart failure and coronary artery disease (CAD) among the elderly, which underscores the increasing reliance on advanced ECG diagnostic solutions to address this critical healthcare need. For instance, as per the February 2024 update by the Turkey Statistical Institute, the proportion of the population aged 65 and over increased from 7.1% in the past decade to 10.6% in 2024. As the geriatric population has grown over the decades, so has the demand for early diagnosis and monitoring of chronic conditions, particularly cardiovascular diseases. This surge in demand is propelling the need for ECG devices in the country.
In Turkey, cardiovascular diseases such as coronary artery disease and cardiac arrests are alarmingly prevalent. As a result, ECG equipment plays a vital role in diagnosing and monitoring these health issues. For instance, as per the article published in July 2024 in the Turkish Journal of Emergency Medicine, the annual incidence rate of out-of-hospital cardiac arrests (OHCAs), where cardiopulmonary resuscitation (CPR) was administered, stands at 56 cases per 100,000 individuals. This underscores the critical need for early detection and monitoring of cardiac conditions, driving the demand for ECG devices in the market as they play a vital role in diagnosing and managing heart-related emergencies.
Moreover, Turkey's market growth is poised to benefit from extensive training initiatives aimed at equipping healthcare professionals with ECG handling skills. For instance, as per the article published in December 2024 in the Eurasian Journal Of Emergency Medicine, interpreting ECGs posed significant challenges, demanding consistent effort for proficiency. However, with the advent of novel algorithmic learning techniques, ECG education has seen marked improvements. The research revealed that the Cardiac Rhythm Identification for Simple People (CRISP) method outperformed conventional methods in enhancing ECG analysis skills. As a result, enhanced training programs will equip more professionals in diagnostic and healthcare facilities to perform ECG analyses, thereby bolstering the country's overall market growth.
In conclusion, the growing geriatric population, high prevalence of cardiovascular diseases, and advancements in training programs are collectively driving the expansion of Turkey's ECG market. These factors are expected to sustain the market's growth trajectory in the coming years, addressing critical healthcare needs and improving patient outcomes. However, the high cost associated with advanced ECG devices may act as a barrier, potentially limiting the market's expansion in the country during the same period.
Turkey Electrocardiograph (ECG) Market Trends
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
Turkey's Holter ECG systems segment is demonstrating robust growth, driven by the systems' benefits in ECG monitoring. This expansion aligns with market trends such as increasing demand for continuous cardiac monitoring, advancements in Holter monitor technology, and heightened public awareness of cardiovascular health. These factors emphasize the segment's critical role in addressing the rising need for accurate and efficient diagnostic solutions within the broader ECG market.
The increasing adoption of Holter ECG Systems by healthcare facilities is anticipated to drive segment growth during the forecast period. For instance, according to an article published in the Clinical Cardiology journal, in November 2024, researchers from Turkey highlighted the use of various ECG monitoring solutions by study participants. These solutions included 12-lead ECG, 24-hour Holter ECG, extended Holter ECG (lasting over 24 hours), and on-demand intermittent monitoring. For on-demand monitoring, participants utilized either single-lead ECG devices, PPG-based devices, or opted for no monitoring, relying instead on clinical follow-ups. The study aimed to evaluate the effectiveness of innovative digital devices for heart rhythm analysis using electrocardiogram (ECG) or photoplethysmography (PPG) technology. Insights from such comparative studies are expected to drive the adoption of advanced ECG systems, contributing to segment growth during the forecast period.
Further, as per an article published in July 2024 in the Support Care Cancer journal, Turkish researchers demonstrated that, while ECGs can detect instantaneous rhythm disturbances, a 24-hour Holter monitor offers a clearer picture of a drug's impact on cardiac rhythm. The researchers closely monitored the drug's influence on cardiac rhythm by capturing Holter rhythm changes at the treatment's onset. These findings underscore the importance of incorporating Holter ECG monitoring into routine cardiac care in Turkey to enhance early detection and management of drug-induced cardiac events.
ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period
In Turkey, healthcare providers are increasingly turning to ECG management software, a specialized application, to efficiently record, manage, analyze, and store electrocardiogram (ECG) data. In Turkey, the burgeoning market for this software is driven mainly by the rising embrace of digital health technologies, which not only streamline healthcare operations but also bolster patient outcomes. Moreover, advancements in artificial intelligence and cloud-based solutions are amplifying the capabilities of ECG management software, solidifying its status as an indispensable tool in diverse healthcare settings and propelling its swift adoption.
Government support for digitalization and healthcare IT in medical facilities is poised to fuel segment growth in the coming years. For instance, Türkiye's development goals and strategic policies for various sectors are outlined in the 12th Development Plan (2024–2028) and the 2025 Presidential Annual Program. Under this move, the country focuses on competitive production with green and digital transformation for pharmaceutical and medical devices, whereas incorporating advanced technologies is set to harness emerging ECG management software, propelling segment growth in the coming years.
Moreover, the advantages of ECG management software make it increasingly adoptable in Turkish healthcare facilities. For instance, by automating data capture and interpretation, these systems seamlessly integrate with electronic health records (EHRs), minimizing errors and enhancing workflow efficiency. Clinicians benefit from embedded algorithms and machine learning, which enable swift and precise ECG interpretation and thus accelerate patient care decisions.
As coronary interventions become more frequent, the need for continuous monitoring bolstered by historical data has surged, fueling the demand for ECG software. This heightened dependence on ECG software for cardiac management is propelling the market segment's growth during the forecast period. Additionally, the increasing adoption of Holter ECG devices in Turkey highlights the growing emphasis on advanced cardiac monitoring solutions in the region.
Turkey Electrocardiograph (ECG) Industry Overview
The competitive landscape of the electrocardiograph (ECG) market in Turkey is characterized by the combination of global companies and emerging players. The market is semi-consolidated yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include GE HealthCare, Nihon Kohden Corporation, Koninklijke Philips N.V., Schiller, Lepu Medical Technology (Beijing)Co. Ltd., among others.
Turkey Electrocardiograph (ECG) Market Leaders
-
Koninklijke Philips N.V
-
Nihon Kohden Corporation
-
GE HealthCare
-
Schiller
-
Lepu Medical Technology(Beijing)Co.,Ltd
- *Disclaimer: Major Players sorted in no particular order
Turkey Electrocardiograph (ECG) Market News
- February 2025: Acıbadem Health Group inaugurated its 11th hospital in Istanbul, Acıbadem Kartal, enhancing the city's healthcare landscape. Acıbadem Kartal operates as a general-purpose facility, offering round-the-clock services tailored to all age groups and diverse health requirements. Boasting a robust infrastructure, the hospital features a versatile modular operating room and cutting-edge radiological imaging technology powered by artificial intelligence. Moreover, the facility is poised to incorporate state-of-the-art ECG products for advanced cardiac monitoring.
- September 2024: Koç Healthcare partnered with Mayo Clinic to integrate American Hospital and Koç University Hospital into the Mayo Clinic Care Network. This collaboration stems from Mayo Clinic's proven expertise in diagnostic and therapeutic advancements. As members of the network, physicians at American Hospital and Koç University Hospital gain access to Mayo Clinic's comprehensive clinical tools and services, facilitating the adoption of advanced ECG devices for improved cardiac care.
Turkey Electrocardiograph (ECG) Industry Segmentation
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Turkey ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Turkey electrocardiograph (ECG) market is segmented by product type, which includes resting systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
By Product Type | Resting ECG Systems |
Stress ECG Systems | |
Holter ECG Systems | |
ECG Management Software |
Resting ECG Systems |
Stress ECG Systems |
Holter ECG Systems |
ECG Management Software |
Turkey Electrocardiograph (ECG) Market Research FAQs
How big is the Turkey Electrocardiograph Market?
The Turkey Electrocardiograph Market size is expected to reach USD 10.83 million in 2025 and grow at a CAGR of 6.31% to reach USD 14.71 million by 2030.
What is the current Turkey Electrocardiograph Market size?
In 2025, the Turkey Electrocardiograph Market size is expected to reach USD 10.83 million.
Who are the key players in Turkey Electrocardiograph Market?
Koninklijke Philips N.V, Nihon Kohden Corporation, GE HealthCare, Schiller and Lepu Medical Technology(Beijing)Co.,Ltd are the major companies operating in the Turkey Electrocardiograph Market.
What years does this Turkey Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Turkey Electrocardiograph Market size was estimated at USD 10.15 million. The report covers the Turkey Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Turkey Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Turkey Electrocardiograph (ECG) Industry Report
Statistics for the 2025 Turkey Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Turkey Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.